SightfileU.S. market data from official filings

Companies › DRIO

DarioHealth Corp (DRIO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001533998 · EDGAR filings · Updated 2026-07-28

DarioHealth Corp (DRIO) has reported institutional ownership of 11.5%, with 21 institutional managers holding positions valued at $6.76M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
11.5%
Institutional managers
21
Reported 13F value
$6.76M
Insider activity
11 trans.
$21.2K net buying
Data flags
3 active
from SEC filings

Filings this week (3)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, DarioHealth Corp has 21 institutional holders and institutional ownership of 11.5%.

Insider activity

Insiders reported 11 transactions (1 buys, 0 sells) across 9 reporting insiders, with a net reported value of $21.2K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-13 (recurring since 2020-03-17) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-03-19 (recurring since 2024-09-20) — source filing. The authoritative details are those stated in the filing itself.
Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2023-02-06 (recurring since 2023-02-06) — source filing. The authoritative details are those stated in the filing itself.

Related companies

CERVOMED INC (CRVO) · TEVOGEN BIO HOLDINGS INC (TVGN) · Lite Strategy Inc (LITS) · Traws Pharma Inc (TRAW) · HARVARD BIOSCIENCE INC (HBIO) · Atossa Therapeutics Inc (ATOS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.